| Item Type | Name |
|
Concept
|
Fatty Liver, Alcoholic
|
|
Concept
|
Hepatitis, Alcoholic
|
|
Concept
|
Liver Cirrhosis, Alcoholic
|
|
Concept
|
Liver Diseases, Alcoholic
|
|
Concept
|
Alcoholics
|
|
Academic Article
|
Fibrosing NASH: on being a blind man in a dark room looking for a black cat (that isn't there).
|
|
Academic Article
|
Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease?
|
|
Academic Article
|
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
|
|
Academic Article
|
Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
|
|
Academic Article
|
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
|
|
Academic Article
|
Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
|
|
Academic Article
|
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
|
|
Academic Article
|
Branched-chain amino acid enriched supplements as therapy for liver disease.
|
|
Academic Article
|
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA.
|
|
Academic Article
|
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
|
Academic Article
|
Nutrition in alcoholic liver disease.
|
|
Academic Article
|
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.
|
|
Academic Article
|
Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.
|
|
Academic Article
|
NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.
|
|
Academic Article
|
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
|
|
Academic Article
|
Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
|
|
Academic Article
|
Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery.
|
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
|
Academic Article
|
The impact of gender and NASH on chronic kidney disease before and after liver transplantation.
|
|
Academic Article
|
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
|
|
Academic Article
|
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis.
|
|
Academic Article
|
Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
|
|
Academic Article
|
Nonalcoholic Fatty Liver Disease and Liver Transplantation.
|
|
Academic Article
|
Alcoholic Liver Disease and Liver Transplantation.
|
|
Academic Article
|
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
|
|
Academic Article
|
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
|
|
Academic Article
|
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
|
|
Academic Article
|
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
|
|
Academic Article
|
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
|
|
Academic Article
|
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib.
|
|
Academic Article
|
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
|
|
Academic Article
|
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
|
|
Academic Article
|
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.
|
|
Academic Article
|
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
|
|
Academic Article
|
Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
|
|
Academic Article
|
FGF-19 agonism for NASH: a short study of a long disease.
|
|
Academic Article
|
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
|
|
Academic Article
|
The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis.
|
|
Academic Article
|
Nonalcoholic Steatohepatitis After Liver Transplantation.
|
|
Academic Article
|
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
|
|
Academic Article
|
Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system.
|
|
Academic Article
|
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
|
|
Academic Article
|
Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
|
|
Academic Article
|
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
|
|
Academic Article
|
Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers.
|
|
Academic Article
|
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study.
|
|
Academic Article
|
Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
|
|
Concept
|
Non-alcoholic Fatty Liver Disease
|
|
Grant
|
Pathophysiology and Characterisation of NAFLD
|
|
Academic Article
|
Liver Transplantation 2023: Status Report, Current and Future Challenges.
|
|
Academic Article
|
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
|
|
Academic Article
|
Macrophage RAGE activation is proinflammatory in NASH.
|
|
Academic Article
|
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
|
|
Academic Article
|
Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort study.
|